Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310128
Status:
WITHDRAWN
Last Update Posted:
2016-02-03
First Post:
2006-03-29
Brief Title:
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkins Lymphoma
Sponsor:
AIDS Malignancy Consortium
Organization:
AIDS Malignancy Consortium
Organization Data
Organization:
AIDS Malignancy Consortium
Class:
NETWORK
Study ID:
AMC-044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AIDS Malignancy Consortium
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |